‹ ›
MYP_104382
← PREVIOUS NEXT → BACK
Basic Information
F478-516
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
39 amino acids
C201H309N51O65
Standard
Sequence
YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV
Physicochemical Analysis
4479.91 Da
4.38
-4.14
-4.41
-0.1062
-0.33
0.65
0.01
45.09
97.44
0.1026
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1892.09
-18.06
62.0
62.0
148.0
317.0
7.0
43.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0007594 VERIFIED: YES
Provenance & Taxonomy
Human orthopneumovirus [Virus]
Virus-derived peptide
11250;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
Respiratory syncytial virus (Virus entry); HEp-2
Syncytia assay
PaperNeutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. | Magro M, Andreu D, Gomez-Puertas P, Melero JA, Palomo C. | J Virol. 2010 | PMID:20534864 PMID20534864 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20534864/
RECORD: Rec_0374861 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 76.9%, E 0.0%, T 5.1%, C 17.9% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/